Dr. Dabora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Gove St
East Boston, MA 02128Phone+1 617-569-5800
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1991 - 1994
- Uconn School Of MedicineClass of 1991
Certifications & Licensure
- MA State Medical License 1994 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Clinical Trials
- RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS Start of enrollment: 2005 Dec 20
Publications & Presentations
PubMed
- 13 citationsSimilar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosis.Izabela A. Malinowska, Nancy Lee, Vidhya Kumar, Elizabeth A. Thiele, David Neal Franz
Plos One. 2013-02-20 - 145 citationsMulticenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels DecreaseSandra L. Dabora, David Neal Franz, Stephen Ashwal, Arthur I. Sagalowsky, Francis J. DiMario
Plos One. 2011-09-06 - 34 citationsComparison of three rapamycin dosing schedules in A/J Tsc2 +/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneo...Chelsey L Woodrum, Alison M Nobil, Sandra L. Dabora
Journal of Translational Medicine. 2010-02-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: